Literature DB >> 32755546

Interpretable Clinical Genomics with a Likelihood Ratio Paradigm.

Peter N Robinson1, Vida Ravanmehr2, Julius O B Jacobsen3, Daniel Danis2, Xingmin Aaron Zhang2, Leigh C Carmody2, Michael A Gargano2, Courtney L Thaxton4, Guy Karlebach2, Justin Reese5, Manuel Holtgrewe6, Sebastian Köhler6, Julie A McMurry7, Melissa A Haendel7, Damian Smedley3.   

Abstract

Human Phenotype Ontology (HPO)-based analysis has become standard for genomic diagnostics of rare diseases. Current algorithms use a variety of semantic and statistical approaches to prioritize the typically long lists of genes with candidate pathogenic variants. These algorithms do not provide robust estimates of the strength of the predictions beyond the placement in a ranked list, nor do they provide measures of how much any individual phenotypic observation has contributed to the prioritization result. However, given that the overall success rate of genomic diagnostics is only around 25%-50% or less in many cohorts, a good ranking cannot be taken to imply that the gene or disease at rank one is necessarily a good candidate. Here, we present an approach to genomic diagnostics that exploits the likelihood ratio (LR) framework to provide an estimate of (1) the posttest probability of candidate diagnoses, (2) the LR for each observed HPO phenotype, and (3) the predicted pathogenicity of observed genotypes. LIkelihood Ratio Interpretation of Clinical AbnormaLities (LIRICAL) placed the correct diagnosis within the first three ranks in 92.9% of 384 case reports comprising 262 Mendelian diseases, and the correct diagnosis had a mean posttest probability of 67.3%. Simulations show that LIRICAL is robust to many typically encountered forms of genomic and phenomic noise. In summary, LIRICAL provides accurate, clinically interpretable results for phenotype-driven genomic diagnostics.
Copyright © 2020 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human Phenotype Ontology; exome sequencing; genome sequencing; liklihood ratio; phenotype-driven genomic diagnostics

Mesh:

Year:  2020        PMID: 32755546      PMCID: PMC7477017          DOI: 10.1016/j.ajhg.2020.06.021

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  51 in total

1.  Phenolyzer: phenotype-based prioritization of candidate genes for human diseases.

Authors:  Hui Yang; Peter N Robinson; Kai Wang
Journal:  Nat Methods       Date:  2015-07-20       Impact factor: 28.547

2.  Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.

Authors:  Tiong Yang Tan; Oliver James Dillon; Zornitza Stark; Deborah Schofield; Khurshid Alam; Rupendra Shrestha; Belinda Chong; Dean Phelan; Gemma R Brett; Emma Creed; Anna Jarmolowicz; Patrick Yap; Maie Walsh; Lilian Downie; David J Amor; Ravi Savarirayan; George McGillivray; Alison Yeung; Heidi Peters; Susan J Robertson; Aaron J Robinson; Ivan Macciocca; Simon Sadedin; Katrina Bell; Alicia Oshlack; Peter Georgeson; Natalie Thorne; Clara Gaff; Susan M White
Journal:  JAMA Pediatr       Date:  2017-09-01       Impact factor: 16.193

3.  On the use and computation of likelihood ratios in clinical chemistry.

Authors:  A Albert
Journal:  Clin Chem       Date:  1982-05       Impact factor: 8.327

4.  Detecting false-positive signals in exome sequencing.

Authors:  Karin V Fuentes Fajardo; David Adams; Christopher E Mason; Murat Sincan; Cynthia Tifft; Camilo Toro; Cornelius F Boerkoel; William Gahl; Thomas Markello
Journal:  Hum Mutat       Date:  2012-03-05       Impact factor: 4.878

5.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.

Authors:  Peter N Robinson; Sebastian Köhler; Sebastian Bauer; Dominik Seelow; Denise Horn; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2008-10-23       Impact factor: 11.025

6.  Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia.

Authors:  Carsten Bergmann; Manfred Fliegauf; Nadina Ortiz Brüchle; Valeska Frank; Heike Olbrich; Jan Kirschner; Bernhard Schermer; Ingolf Schmedding; Andreas Kispert; Bettina Kränzlin; Gudrun Nürnberg; Christian Becker; Tiemo Grimm; Gundula Girschick; Sally A Lynch; Peter Kelehan; Jan Senderek; Thomas J Neuhaus; Thomas Stallmach; Hanswalter Zentgraf; Peter Nürnberg; Norbert Gretz; Cecilia Lo; Soeren Lienkamp; Tobias Schäfer; Gerd Walz; Thomas Benzing; Klaus Zerres; Heymut Omran
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

7.  VarElect: the phenotype-based variation prioritizer of the GeneCards Suite.

Authors:  Gil Stelzer; Inbar Plaschkes; Danit Oz-Levi; Anna Alkelai; Tsviya Olender; Shahar Zimmerman; Michal Twik; Frida Belinky; Simon Fishilevich; Ron Nudel; Yaron Guan-Golan; David Warshawsky; Dvir Dahary; Asher Kohn; Yaron Mazor; Sergey Kaplan; Tsippi Iny Stein; Hagit N Baris; Noa Rappaport; Marilyn Safran; Doron Lancet
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

Review 8.  The Human Phenotype Ontology in 2017.

Authors:  Sebastian Köhler; Nicole A Vasilevsky; Mark Engelstad; Erin Foster; Julie McMurry; Ségolène Aymé; Gareth Baynam; Susan M Bello; Cornelius F Boerkoel; Kym M Boycott; Michael Brudno; Orion J Buske; Patrick F Chinnery; Valentina Cipriani; Laureen E Connell; Hugh J S Dawkins; Laura E DeMare; Andrew D Devereau; Bert B A de Vries; Helen V Firth; Kathleen Freson; Daniel Greene; Ada Hamosh; Ingo Helbig; Courtney Hum; Johanna A Jähn; Roger James; Roland Krause; Stanley J F Laulederkind; Hanns Lochmüller; Gholson J Lyon; Soichi Ogishima; Annie Olry; Willem H Ouwehand; Nikolas Pontikos; Ana Rath; Franz Schaefer; Richard H Scott; Michael Segal; Panagiotis I Sergouniotis; Richard Sever; Cynthia L Smith; Volker Straub; Rachel Thompson; Catherine Turner; Ernest Turro; Marijcke W M Veltman; Tom Vulliamy; Jing Yu; Julie von Ziegenweidt; Andreas Zankl; Stephan Züchner; Tomasz Zemojtel; Julius O B Jacobsen; Tudor Groza; Damian Smedley; Christopher J Mungall; Melissa Haendel; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.

Authors:  Sebastian Köhler; Leigh Carmody; Nicole Vasilevsky; Julius O B Jacobsen; Daniel Danis; Jean-Philippe Gourdine; Michael Gargano; Nomi L Harris; Nicolas Matentzoglu; Julie A McMurry; David Osumi-Sutherland; Valentina Cipriani; James P Balhoff; Tom Conlin; Hannah Blau; Gareth Baynam; Richard Palmer; Dylan Gratian; Hugh Dawkins; Michael Segal; Anna C Jansen; Ahmed Muaz; Willie H Chang; Jenna Bergerson; Stanley J F Laulederkind; Zafer Yüksel; Sergi Beltran; Alexandra F Freeman; Panagiotis I Sergouniotis; Daniel Durkin; Andrea L Storm; Marc Hanauer; Michael Brudno; Susan M Bello; Murat Sincan; Kayli Rageth; Matthew T Wheeler; Renske Oegema; Halima Lourghi; Maria G Della Rocca; Rachel Thompson; Francisco Castellanos; James Priest; Charlotte Cunningham-Rundles; Ayushi Hegde; Ruth C Lovering; Catherine Hajek; Annie Olry; Luigi Notarangelo; Morgan Similuk; Xingmin A Zhang; David Gómez-Andrés; Hanns Lochmüller; Hélène Dollfus; Sergio Rosenzweig; Shruti Marwaha; Ana Rath; Kathleen Sullivan; Cynthia Smith; Joshua D Milner; Dorothée Leroux; Cornelius F Boerkoel; Amy Klion; Melody C Carter; Tudor Groza; Damian Smedley; Melissa A Haendel; Chris Mungall; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.

Authors:  Stéphanie Nguengang Wakap; Deborah M Lambert; Annie Olry; Charlotte Rodwell; Charlotte Gueydan; Valérie Lanneau; Daniel Murphy; Yann Le Cam; Ana Rath
Journal:  Eur J Hum Genet       Date:  2019-09-16       Impact factor: 4.246

View more
  11 in total

1.  The utility of pathologic examination and comprehensive phenotyping for accurate diagnosis with perinatal exome sequencing.

Authors:  Kate Swanson; Mary E Norton; Billie R Lianoglou; Angie C Jelin; Ugur Hodoglugil; Jessica Van Ziffle; Patrick Devine; Teresa N Sparks
Journal:  Prenat Diagn       Date:  2022-07-03       Impact factor: 3.242

2.  Creation and evaluation of full-text literature-derived, feature-weighted disease models of genetically determined developmental disorders.

Authors:  T M Yates; A Lain; J Campbell; D R FitzPatrick; T I Simpson
Journal:  Database (Oxford)       Date:  2022-06-07       Impact factor: 4.462

Review 3.  Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery.

Authors:  David Lewis-Smith; Shridhar Parthasarathy; Julie Xian; Michael C Kaufman; Shiva Ganesan; Peter D Galer; Rhys H Thomas; Ingo Helbig
Journal:  Hum Mutat       Date:  2022-05-22       Impact factor: 4.700

4.  The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice.

Authors:  Hui-Lin Chin; Nour Gazzaz; Stephanie Huynh; Iulia Handra; Lynn Warnock; Ashley Moller-Hansen; Pierre Boerkoel; Julius O B Jacobsen; Christèle du Souich; Nan Zhang; Kent Shefchek; Leah M Prentice; Nicole Washington; Melissa Haendel; Linlea Armstrong; Lorne Clarke; Wenhui Laura Li; Damian Smedley; Peter N Robinson; Cornelius F Boerkoel
Journal:  Genet Med       Date:  2022-04-19       Impact factor: 8.864

5.  Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs.

Authors:  Justin Reese; Hannah Blau; Timothy Bergquist; Johanna J Loomba; Tiffany Callahan; Bryan Laraway; Corneliu Antonescu; Elena Casiraghi; Ben Coleman; Michael Gargano; Kenneth Wilkins; Luca Cappelletti; Tommaso Fontana; Nariman Ammar; Blessy Antony; T M Murali; Guy Karlebach; Julie A McMurry; Andrew Williams; Richard Moffitt; Jineta Banerjee; Anthony E Solomonides; Hannah Davis; Kristin Kostka; Giorgio Valentini; David Sahner; Christopher G Chute; Charisse Madlock-Brown; Melissa A Haendel; Peter N Robinson
Journal:  medRxiv       Date:  2022-05-25

Review 6.  Phenotype-driven approaches to enhance variant prioritization and diagnosis of rare disease.

Authors:  Julius O B Jacobsen; Catherine Kelly; Valentina Cipriani; Genomics England Research Consortium; Christopher J Mungall; Justin Reese; Daniel Danis; Peter N Robinson; Damian Smedley
Journal:  Hum Mutat       Date:  2022-04-27       Impact factor: 4.700

7.  The Human Phenotype Ontology in 2021.

Authors:  Sebastian Köhler; Michael Gargano; Nicolas Matentzoglu; Leigh C Carmody; David Lewis-Smith; Nicole A Vasilevsky; Daniel Danis; Ganna Balagura; Gareth Baynam; Amy M Brower; Tiffany J Callahan; Christopher G Chute; Johanna L Est; Peter D Galer; Shiva Ganesan; Matthias Griese; Matthias Haimel; Julia Pazmandi; Marc Hanauer; Nomi L Harris; Michael J Hartnett; Maximilian Hastreiter; Fabian Hauck; Yongqun He; Tim Jeske; Hugh Kearney; Gerhard Kindle; Christoph Klein; Katrin Knoflach; Roland Krause; David Lagorce; Julie A McMurry; Jillian A Miller; Monica C Munoz-Torres; Rebecca L Peters; Christina K Rapp; Ana M Rath; Shahmir A Rind; Avi Z Rosenberg; Michael M Segal; Markus G Seidel; Damian Smedley; Tomer Talmy; Yarlalu Thomas; Samuel A Wiafe; Julie Xian; Zafer Yüksel; Ingo Helbig; Christopher J Mungall; Melissa A Haendel; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

8.  Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases.

Authors:  Francisco M De La Vega; Shimul Chowdhury; Barry Moore; Erwin Frise; Jeanette McCarthy; Edgar Javier Hernandez; Terence Wong; Kiely James; Lucia Guidugli; Pankaj B Agrawal; Casie A Genetti; Catherine A Brownstein; Alan H Beggs; Britt-Sabina Löscher; Andre Franke; Braden Boone; Shawn E Levy; Katrin Õunap; Sander Pajusalu; Matt Huentelman; Keri Ramsey; Marcus Naymik; Vinodh Narayanan; Narayanan Veeraraghavan; Paul Billings; Martin G Reese; Mark Yandell; Stephen F Kingsmore
Journal:  Genome Med       Date:  2021-10-14       Impact factor: 11.117

9.  Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases.

Authors:  Xiao Yuan; Jing Wang; Bing Dai; Yanfang Sun; Keke Zhang; Fangfang Chen; Qian Peng; Yixuan Huang; Xinlei Zhang; Junru Chen; Xilin Xu; Jun Chuan; Wenbo Mu; Huiyuan Li; Ping Fang; Qiang Gong; Peng Zhang
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

10.  Advances in the development of PubCaseFinder, including the new application programming interface and matching algorithm.

Authors:  Toyofumi Fujiwara; Jae-Moon Shin; Atsuko Yamaguchi
Journal:  Hum Mutat       Date:  2022-02-22       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.